These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 7543680)
1. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Yoshiura K; Kanai Y; Ochiai A; Shimoyama Y; Sugimura T; Hirohashi S Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7416-9. PubMed ID: 7543680 [TBL] [Abstract][Full Text] [Related]
2. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913 [TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Si HX; Tsao SW; Lam KY; Srivastava G; Liu Y; Wong YC; Shen ZY; Cheung AL Cancer Lett; 2001 Nov; 173(1):71-8. PubMed ID: 11578811 [TBL] [Abstract][Full Text] [Related]
4. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma. Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972 [TBL] [Abstract][Full Text] [Related]
5. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631 [TBL] [Abstract][Full Text] [Related]
6. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Nakayama S; Sasaki A; Mese H; Alcalde RE; Tsuji T; Matsumura T Int J Cancer; 2001 Sep; 93(5):667-73. PubMed ID: 11477576 [TBL] [Abstract][Full Text] [Related]
7. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750 [TBL] [Abstract][Full Text] [Related]
8. Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5' CpG island. Saito Y; Takazawa H; Uzawa K; Tanzawa H; Sato K Int J Oncol; 1998 Feb; 12(2):293-8. PubMed ID: 9458351 [TBL] [Abstract][Full Text] [Related]
9. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells]. Qu PP; Shi Z; Li N Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells. Maeda G; Chiba T; Aoba T; Imai K Odontology; 2007 Jul; 95(1):24-9. PubMed ID: 17660978 [TBL] [Abstract][Full Text] [Related]
11. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Chang HW; Chow V; Lam KY; Wei WI; Yuen A Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224 [TBL] [Abstract][Full Text] [Related]
12. E-cadherin gene mutations in human gastric carcinoma cell lines. Oda T; Kanai Y; Oyama T; Yoshiura K; Shimoyama Y; Birchmeier W; Sugimura T; Hirohashi S Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1858-62. PubMed ID: 8127895 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Bae SI; Lee HS; Kim SH; Kim WH Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181 [TBL] [Abstract][Full Text] [Related]
14. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837 [TBL] [Abstract][Full Text] [Related]
15. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Chiles MC; Ai L; Zuo C; Fan CY; Smoller BR Mod Pathol; 2003 Oct; 16(10):1014-8. PubMed ID: 14559984 [TBL] [Abstract][Full Text] [Related]
16. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458 [TBL] [Abstract][Full Text] [Related]
18. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma. Kao RH; Huang LC; Hsu YH Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040 [TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Graff JR; Greenberg VE; Herman JG; Westra WH; Boghaert ER; Ain KB; Saji M; Zeiger MA; Zimmer SG; Baylin SB Cancer Res; 1998 May; 58(10):2063-6. PubMed ID: 9605742 [TBL] [Abstract][Full Text] [Related]